摘要
目的分析综合疗法在慢性盆腔炎中的临床疗效。方法选取2015年1月至2016年10月我院收治的100例慢性盆腔炎患者作为研究对象,随机分为观察组与对照组,每组50例。对照组使用西药治疗,观察组在对照组的基础上加入中成药治疗。比较两组患者的临床疗效、不良反应发生率及炎症因子(TNF-α、IL-1β、IL-8)水平。结果观察组患者的治疗有效率高于对照组(P<0.05);治疗前,两组患者TNF-α、IL-1β、IL-8水平比较,差异不显著(P>0.05);治疗后,两组患者的TNF-α、IL-1β、IL-8水平均降低,且观察组低于对照组(P<0.05);两组治疗期间均无严重不良反应发生。结论中西医综合疗法在慢性盆腔炎中具有较好的应用效果,能够有效提升临床疗效,且安全性高,值得推广使用。
Objective To analyze the clinical efficacy of comprehensive therapy on chronic pelvic inflammatory disease.Methods One hundred cases of patients with chronic pelvic inflammatory disease treated in our hospital from January 2015 to October 2016 were seleced and randomly divided into observation group and control group, 50 cases in each group. The control group was treated with western medicine, while the observation group was treated with Chinese medicine on the basis of the control group. The clinical efficacy, incidence of adverse reactions and the levels of inflammatory cytokines（TNF-α、IL-1β、IL-8） were compared between the two groups. Results The effective rate of the observation group was significantly higher than that of the control group（P0.05）. Before treatment, the levels of TNF-α, IL-1β, IL-8 in the two groups were not significant different（P〉0.05）; after treatment, the levels of TNF-α, IL-1β, IL-8 in the two groups decreased, and those of the observation group were lower than the control group（P〈0.05）. There were no serious adverse reactions occurred during the treatment in the two groups. Conclusion The comprehensive treatment of traditional Chinese medicine and Western medicine has good effect in the treatment of chronic pelvic inflammatory disease, it can effectively improve the clinical efficacy, with high safety, which is worthy of promotion and application.
出处
《临床医学研究与实践》
2017年第34期101-102,共2页
Clinical Research and Practice
关键词
慢性盆腔炎
综合疗法
临床疗效
chronic pelvic inflammatory disease
comprehensive therapy
clinical effect
